EKSO BIONICS HOLDINGS, INC. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ekso Bionics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Ekso Bionics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.64M, a 9.96% increase year-over-year.
  • Ekso Bionics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.7M, a 27.5% increase year-over-year.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$15.1M, a 2.85% increase from 2022.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$15.6M, a 12.5% decline from 2021.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2021 was -$13.8M, a 4.04% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$11.7M -$2.64M +$292K +9.96% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-28
Q2 2024 -$12M -$2.34M +$1.95M +45.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 -$13.9M -$3.26M +$1.19M +26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 -$15.1M -$3.45M +$987K +22.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 -$16.1M -$2.93M +$723K +19.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-28
Q2 2023 -$16.8M -$4.28M -$1.06M -32.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 -$15.8M -$4.45M -$211K -4.98% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 -$15.6M -$4.44M +$116K +2.55% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 -$15.7M -$3.65M -$865K -31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$14.8M -$3.23M +$119K +3.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 -$14.9M -$4.24M -$1.1M -35% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$13.8M -$4.55M -$1.56M -51.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$12.3M -$2.79M -$368K -15.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$11.9M -$3.35M -$256K -8.28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 -$11.6M -$3.14M +$1.64M +34.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 -$13.3M -$3M -$158K -5.57% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$13.1M -$2.42M +$1.37M +36.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$14.5M -$3.09M +$2.01M +39.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$16.5M -$4.78M +$131K +2.67% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 -$16.6M -$2.84M +$2.3M +44.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$18.9M -$3.79M +$2.3M +37.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$21.2M -$5.1M +$2.09M +29% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$23.3M -$4.91M +$3.7M +43% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$27M -$5.14M +$2.81M +35.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$29.8M -$6.09M +$972K +13.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$30.8M -$7.19M +$1.27M +15.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$32.1M -$8.61M -$472K -5.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 -$31.6M -$7.95M -$1.26M -18.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$30.3M -$7.07M -$200K -2.91% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$30.1M -$8.46M -$1.06M -14.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$29.1M -$8.14M -$1.5M -22.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$27.6M -$6.68M -$30K -0.45% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$27.6M -$6.87M -$1.69M -32.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$25.9M -$7.4M -$1.76M -31.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$24.1M -$6.64M -$2.55M -62.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$21.6M -$6.65M -$1.79M -36.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 -$19.8M -$5.18M -$1.45M -38.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$18.3M -$5.64M -$1.32M -30.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$17M -$4.09M -$202K -5.19% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$16.8M -$4.86M -$4.85M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$11.9M -$3.73M -$2.06M -123% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$9.88M -$4.31M -$1.6M -59.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$8.28M -$3.89M -$736K -23.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$7.54M -$6.08K* -$4.3K Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-19
Q3 2013 -$7.54M -$1.67M -$1.67M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$5.87M -$2.71M +$2.18M +44.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.05M -$3.15M +$1.5M +32.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$9.56M -$1.78K* Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q3 2012 -$1.25K* Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
Q2 2012 -$4.9M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$4.66M Jan 30, 2012 Mar 31, 2012 10-K 2013-07-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.